AB SCIEX and Indigo Team Up to Market Clinical and Forensic Mass Spectrometry Solutions

AB SCIEX and Indigo BioSystems have announced an agreement to jointly market mass spectrometry solutions that streamline data acquisition and automate data review. The joint solutions have been designed to ensure high quality results in clinical research and forensic toxicology, as well as the pre-clinical and clinical trials of new drugs.

The agreement means that AB SCIEX will combine its industry-leading mass spectrometry platforms with Indigo BioSystem’s expert system software ASCENT^TM , to simplify and accelerate the use of new-generation mass spectrometry technologies. ASCENT^TM software has new-generation algorithms to simplify the use of mass spectrometry for scientists who are accustomed to easy-to-use lab analyzers. The software automates the processing and review of data generated by AB SCIEX systems, to provide the most accurate data possible with identification, quantitation and confirmation uniquely rolled up in a single workflow.

AB SCIEX is a global leader in mass spectrometry technologies. Its state-of-the-art LC/MS/MS (liquid chromatography/tandem mass spectrometry) has set a new standard in qualitative and quantitative analysis for clinical research and forensic toxicology laboratories as well as pharmaceutical companies and biomedical researchers in academia.

“Automation is an important step to accelerate the adoption of new-generation mass spectrometry for clinical research, forensics and clinical trials,” said Joe Anacleto, Vice President of Applied Markets and Clinical Research, AB SCIEX. “We are striving to make mass spectrometry as easy to use as possible for researchers analyzing steroids, pain panels, drugs of abuse and an expanding variety of substances. Our relationship with Indigo BioSystems allows us to bring LC/MS/MS solutions to researchers who may not ordinarily consider mass spectrometry but can now have the assurance of a simplified workflow while getting all the attractive benefits of LC/MS/MS technology.”

The combination of AB SCIEX’s and Indigo’s technologies will ensure the accuracy of results, speed up batch release and increase compliance with QC rules needed to ensure high quality.

“By embedding the knowledge of assay experts into the analysis software, we provide the foundation for smarter research laboratories,” said Indigo CEO Raul Zavaleta. “We are pleased to be partnering with the industry leader in LC/MS/MS to achieve this goal.”